annual FCF:
-$38.29M-$6.44M(-20.23%)Summary
- As of today (September 16, 2025), TRVI annual free cash flow is -$38.29 million, with the most recent change of -$6.44 million (-20.23%) on December 31, 2024.
- During the last 3 years, TRVI annual FCF has fallen by -$9.35 million (-32.28%).
- TRVI annual FCF is now -242.13% below its all-time high of -$11.19 million, reached on December 1, 2016.
Performance
TRVI Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$10.10M+$3.38M(+25.05%)Summary
- As of today (September 16, 2025), TRVI quarterly free cash flow is -$10.10 million, with the most recent change of +$3.38 million (+25.05%) on June 30, 2025.
- Over the past year, TRVI quarterly FCF has dropped by -$1.39 million (-15.96%).
- TRVI quarterly FCF is now -146.07% below its all-time high of -$4.11 million, reached on March 31, 2019.
Performance
TRVI quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$42.69M-$1.39M(-3.37%)Summary
- As of today (September 16, 2025), TRVI TTM free cash flow is -$42.69 million, with the most recent change of -$1.39 million (-3.37%) on June 30, 2025.
- Over the past year, TRVI TTM FCF has dropped by -$9.84 million (-29.93%).
- TRVI TTM FCF is now -659.63% below its all-time high of -$5.62 million, reached on June 30, 2018.
Performance
TRVI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
TRVI Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -20.2% | -16.0% | -29.9% |
3 y3 years | -32.3% | -63.5% | -59.7% |
5 y5 years | -65.8% | -19.6% | -57.8% |
TRVI Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -35.1% | at low | -63.5% | +25.1% | -59.7% | at low |
5 y | 5-year | -65.8% | at low | -63.5% | +25.1% | -62.3% | at low |
alltime | all time | -242.1% | at low | -146.1% | +25.1% | -659.6% | at low |
TRVI Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$10.10M(-25.1%) | -$42.69M(+3.4%) |
Mar 2025 | - | -$13.48M(+41.0%) | -$41.30M(+7.9%) |
Dec 2024 | -$38.29M(+20.2%) | -$9.56M(+0.0%) | -$38.29M(+9.0%) |
Sep 2024 | - | -$9.56M(+9.7%) | -$35.12M(+6.9%) |
Jun 2024 | - | -$8.71M(-16.8%) | -$32.86M(-3.5%) |
Mar 2024 | - | -$10.47M(+64.0%) | -$34.06M(+6.9%) |
Dec 2023 | -$31.85M(+12.4%) | -$6.38M(-12.6%) | -$31.85M(-0.2%) |
Sep 2023 | - | -$7.30M(-26.4%) | -$31.91M(-4.0%) |
Jun 2023 | - | -$9.91M(+20.1%) | -$33.23M(+12.7%) |
Mar 2023 | - | -$8.25M(+28.0%) | -$29.50M(+4.1%) |
Dec 2022 | -$28.33M(-2.1%) | -$6.45M(-25.2%) | -$28.33M(+0.8%) |
Sep 2022 | - | -$8.62M(+39.6%) | -$28.12M(+5.2%) |
Jun 2022 | - | -$6.18M(-12.9%) | -$26.74M(-6.1%) |
Mar 2022 | - | -$7.09M(+13.9%) | -$28.46M(-1.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$28.95M(-0.3%) | -$6.23M(-14.0%) | -$28.95M(-8.5%) |
Sep 2021 | - | -$7.24M(-8.3%) | -$31.65M(+0.8%) |
Jun 2021 | - | -$7.90M(+4.2%) | -$31.39M(-1.7%) |
Mar 2021 | - | -$7.58M(-15.1%) | -$31.94M(+10.0%) |
Dec 2020 | -$29.03M(+25.7%) | -$8.93M(+27.9%) | -$29.03M(+10.4%) |
Sep 2020 | - | -$6.98M(-17.4%) | -$26.30M(-2.8%) |
Jun 2020 | - | -$8.45M(+80.8%) | -$27.06M(+14.3%) |
Mar 2020 | - | -$4.67M(-24.7%) | -$23.67M(+2.5%) |
Dec 2019 | -$23.10M(+25.0%) | -$6.20M(-19.8%) | -$23.10M(+6.3%) |
Sep 2019 | - | -$7.73M(+52.8%) | -$21.72M(+55.3%) |
Jun 2019 | - | -$5.06M(+23.3%) | -$13.99M(-3.8%) |
Mar 2019 | - | -$4.11M(-14.9%) | -$14.55M(+39.3%) |
Dec 2018 | -$18.48M(+65.1%) | -$4.82M(-14.2%) | -$10.44M(+85.8%) |
Jun 2018 | - | -$5.62M | -$5.62M |
Dec 2016 | -$11.19M | - | - |
FAQ
- What is Trevi Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. annual FCF year-on-year change?
- What is Trevi Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Trevi Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. TTM FCF year-on-year change?
What is Trevi Therapeutics, Inc. annual free cash flow?
The current annual FCF of TRVI is -$38.29M
What is the all time high annual FCF for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high annual free cash flow is -$11.19M
What is Trevi Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, TRVI annual free cash flow has changed by -$6.44M (-20.23%)
What is Trevi Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of TRVI is -$10.10M
What is the all time high quarterly FCF for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high quarterly free cash flow is -$4.11M
What is Trevi Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, TRVI quarterly free cash flow has changed by -$1.39M (-15.96%)
What is Trevi Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of TRVI is -$42.69M
What is the all time high TTM FCF for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high TTM free cash flow is -$5.62M
What is Trevi Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, TRVI TTM free cash flow has changed by -$9.84M (-29.93%)